CN1181878C - Detumescence plaster - Google Patents
Detumescence plaster Download PDFInfo
- Publication number
- CN1181878C CN1181878C CNB021589283A CN02158928A CN1181878C CN 1181878 C CN1181878 C CN 1181878C CN B021589283 A CNB021589283 A CN B021589283A CN 02158928 A CN02158928 A CN 02158928A CN 1181878 C CN1181878 C CN 1181878C
- Authority
- CN
- China
- Prior art keywords
- treatment
- fine powder
- ointment
- detumescence
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an externally-applied traditional Chinese medicinal preparation, namely a detumescence ointment, for treating joint swelling, which belongs to the technical field of medicines. The detumescence ointment is characterized in that one dosage of detumescence ointment comprises the medicinal ingredients according to weight ratio of 5000 to 8000g of bark of Chinese redbud, 2000 to 6000g of phellodendron bark, 1000 to 6000g of atractylodes rhizome, 5000 to 10000g of grassleaf sweetflag rhizome, 2000 to 6000g of red peony root and 3000 to 8000g of doubleteeth pubesscent angelica root. The medicinal ingredients taken by weight percentage are dried, sterilized and pulverized into fine powder of about 130 meshes, and the fine powder is separately packed by 200 g/bag. While in use, the fine powder is prepared into an ointment form by adding water. The present invention achieves the purposes of eliminating swelling, alleviating pain, improving functions and enhancing the quality of life by adopting various traditional Chinese medicines to optimize the prescription. The prepared externally-applied preparation has the advantages of convenient use, simple preparation process and low cost. The clinical tests of the detumescence ointment medicine of the present invention are finished. Through clinical application of 1020 patients with joint swelling by the treatment of the classification of diseases, the cure rate is 24.2%, and the total effective rate is 99.41%.
Description
Technical field
The present invention is a field of pharmaceutical technology, relates to a kind of external Chinese powder medicine for the treatment of arthroncus.
Background technology
Arthroncus is clinical common a kind of sign, seriously influences patient's orthobiosis and work.Many factors can cause arthroncus, as mechanical wear, the heavy burden of the non-line of force, crystallization deposition arthropathy or the like.The disease that causes arthroncus is a lot, and common have osteoarthritis, rheumatic arthropathy, crystal induced arthritis, bursitis or the like.Sickness rate for arthroncus does not now have unified report, and the pathogeny of arthroncus is due to illness because of different.At first tackling its primary disease and treat, secondly is symptomatic treatment.At present main Therapeutic Method has naturopathy and Drug therapy, and naturopathy required treatment time is longer, because treatment time is longer, the patient can not finish the required course of treatment sometimes.The side effect of oral drugs is bigger, and it is slow to take effect.Chinese medicine dialectical execute control, the difference of method such as prescription, dosage form, processing technique, curative effect is widely different.What Chinese patent 00123104.9 related to by retrieval is a kind of application compress, is a kind of ointment for treating traumatic injury, setting fracture and eliminating swelling.And Chinese patent 00114556.8 is a kind of repercussive Chinese medicine mastic that is used for more creating.The Chinese medicine for outer use that the treatment arthroncus is not also arranged at present.
Summary of the invention
The objective of the invention is provides a kind of external Chinese powder medicine for the treatment of arthroncus for overcoming above-mentioned treatment shortcoming.
A kind of external Chinese powder medicine content Description for the treatment of arthroncus of the present invention:
A kind of external Chinese powder medicine for the treatment of arthroncus of the present invention, it is characterized in that: it is made up of the component of following consumption, and ampoule is: Cortex cercis chinensis 5000～8000g, Cortex Phellodendri 2000～6000g, Rhizoma Atractylodis 1000～6000g, Rhizoma Acori Graminei 5000～10000g, Radix Paeoniae Rubra 2000～6000g and Radix Angelicae Pubescentis 3000～8000g.
It is made by following method: get it filled by consumption, dry sterilization, be crushed into 130 purpose fine powders, packing 200g/ bag tempers into paste during use.
The present invention is a kind of external Chinese powder medicine for the treatment of arthroncus, adopts plurality of Chinese to optimize prescription, the purpose that reaches reducing swelling and alleviating pain, improves function, improves the quality of living.Make external preparation, easy to use, preparation technology is simple, with low cost.Clinical trial of the present invention is finished, the patient of 1020 routine arthroncuss is carried out classification of diseases execute and control clinical practice, and wherein the course of disease is the longest 6 months, the shortest 7 days; Wherein: bursitis 284 examples, osteoarthritis 340 examples, rheumatoid arthritis 52 examples, wound 144 examples.
Criterion of therapeutical effect:
Cure: clinical symptoms and arthroncus complete obiteration, function are normally, daily life is not limited;
Significantly take a turn for the better: clinical symptoms and arthroncus disappear substantially, function of joint is roughly normal;
Take a turn for the better: clinical symptoms and arthroncus alleviate, and function of joint has improvement;
Invalid: clinical symptoms and arthroncus do not have obvious improvement.
| Classification | The example number | Excellent | Account for % | Very | Account for % | Effectively | Account for % | Invalid | Account for % |
| Bursitis osteoarthritis rheumatoid arthritis wound adds up to | 284 340 252 144 1020 | 62 83 49 53 247 | 21.8 24.4 19.4 36.8 24.2 | 99 149 62 51 362 | 34.9 43.9 25 35.4 35.5 | 122 107 137 39 405 | 42.6 31.5 54.4 27.1 39.7 | 1 1 3 1 6 | 0.35 0.29 1.19 0.69 0.6 |
Cure 247 examples through clinical treatment, account for 24.2%, total effective 1014 examples, total effective rate is 99.41%.The shortest 10 days of treatment time, the longest 38 days, the efficacy consolidation relapse rate was lower, checked 879 examples with examining after 3 months to 2 years, and 31 example recurrences are arranged, and the state of an illness is preceding light than treatment, and relapse rate is to follow up a case by regular visits to 3.53% of check case.
The specific embodiment
Embodiment 1
Cause arthroncus patient 284 examples in March, 2000～November calendar year 2001 in Tanggangzi Hospital's prescription on individual diagnosis treatment bursitis, the prescription of seance amount medication is: Cortex cercis chinensis 5000g, Cortex Phellodendri 2000g, Rhizoma Atractylodis 2000g, Rhizoma Acori Graminei 6000g, Radix Paeoniae Rubra 3000g, Radix Angelicae Pubescentis 4000g.
The said medicine prescription got it filled after dry coarse powder, sterilize, be crushed into the fine powder about 130 orders, packing 200g/ bag, water reconciles into paste, and to spread on the affected part after the hot water bag heating, the lid layer soft plastic cloth covers two-layer towel again, increase temperature with hot water bag, applied 2～3 hours every day.Make medicine act on body by skin, get rid of evils and set upright by heating power, warming the meridian and promoting blood circulation, the circulation QI and blood reaches the purpose of curing the disease.Reach 99.4% through the treatment total effective rate.
Embodiment 2
Cause arthroncus patient 340 examples in March, 2000～November in Anshan soup mound hospital admission treatment rheumatoid arthritis, the prescription of seance amount medication is: Cortex cercis chinensis 8000g, Cortex Phellodendri 3000g, Rhizoma Atractylodis 4000, Rhizoma Acori Graminei 7000g, Radix Paeoniae Rubra 4000g, Radix Angelicae Pubescentis 6000g.
The said medicine prescription got it filled after dry coarse powder, sterilize, be crushed into the fine powder about 130 orders, packing 200g/ bag, water reconciles into paste, and to spread on the affected part after the hot water bag heating, the lid layer soft plastic cloth covers two-layer towel again, increase temperature with hot water bag, every order applied 2～3 hours.Make medicine act on body by skin, get rid of evils and set upright by heating power, warming the meridian and promoting blood circulation, the venting QI-blood that relaxes reaches the purpose of curing the disease.Reach 98.8% through the treatment total effective rate.
Embodiment 3
Cause arthroncus patient 144 examples in Anshan soup mound hospital admission treatment wound year November in April, 2000～2002, the prescription of seance amount medication is: Cortex cercis chinensis 6000g, Cortex Phellodendri 6000g, Rhizoma Atractylodis 3000, Rhizoma Acori Graminei 6000g, Radix Paeoniae Rubra 3000g, Radix Angelicae Pubescentis 3000g.
The said medicine prescription got it filled after dry coarse powder, sterilize, be crushed into the fine powder about 130 orders, packing 200g/ bag, water reconciles into paste, and to spread on the affected part after the hot water bag heating, the lid layer soft plastic cloth covers two-layer towel again, increase temperature with hot water bag, applied 2～3 hours every day.Make medicine act on body by skin, get rid of evils and set upright by heating power, warming the meridian and promoting blood circulation, the venting QI-blood that relaxes reaches the purpose of curing the disease.Reach 99.3% through the treatment total effective rate.
Have promoting blood circulation to restore menstrual flow, subduing swelling and detoxicating according to pharmacological research proof Cortex cercis chinensis; Radix Paeoniae Rubra, Rhizoma Atractylodis, Radix Angelicae Pubescentis have the effect of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, expelling wind and removing dampness; The hot temperature of loosing of Rhizoma Acori Graminei is logical.The present invention serves as the comprehensive prescription of treatment with blood circulation promoting and blood stasis dispelling, dredging the meridian.By eliminating swelling, ease the pain, improve function.
Claims (2)
1, a kind of external Chinese powder medicine for the treatment of arthroncus, it is characterized in that: it is made up of the component of following consumption: Cortex cercis chinensis 5000～8000g, Cortex Phellodendri 2000～6000g, Rhizoma Atractylodis 1000～6000g, Rhizoma Acori Graminei 5000～10000g, Radix Paeoniae Rubra 2000～6000g and Radix Angelicae Pubescentis 3000～8000g.
2, a kind of external Chinese powder medicine as claimed in claim 1, it is characterized in that: it is made by following method: get it filled by consumption, dry sterilization, be crushed into 130 purpose fine powders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021589283A CN1181878C (en) | 2002-12-27 | 2002-12-27 | Detumescence plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021589283A CN1181878C (en) | 2002-12-27 | 2002-12-27 | Detumescence plaster |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1424094A CN1424094A (en) | 2003-06-18 |
| CN1181878C true CN1181878C (en) | 2004-12-29 |
Family
ID=4753212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021589283A Expired - Fee Related CN1181878C (en) | 2002-12-27 | 2002-12-27 | Detumescence plaster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1181878C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526387B (en) * | 2012-02-27 | 2014-01-15 | 天津中医药大学 | Medicinal composition for treating early-stage diabetic foot and preparation method thereof |
| CN104138480A (en) * | 2013-05-08 | 2014-11-12 | 百家康健(天津)生物科技有限公司 | Redness swelling eliminating ointment |
| CN104116871A (en) * | 2014-08-11 | 2014-10-29 | 周盈裕 | Traditional Chinese medicine paste for treating ulcers |
| CN104887869A (en) * | 2015-05-24 | 2015-09-09 | 太仓思瑞生物科技有限公司 | Plaster for treating osteoarthritis |
| CN104887868A (en) * | 2015-05-24 | 2015-09-09 | 太仓思瑞生物科技有限公司 | Plaster for treating arthritis |
| CN105582474A (en) * | 2016-02-02 | 2016-05-18 | 赵佳睿 | Paste capable of stopping pain and relieving swelling |
-
2002
- 2002-12-27 CN CNB021589283A patent/CN1181878C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1424094A (en) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1181878C (en) | Detumescence plaster | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1302800C (en) | Chinese traditional medicine preparation for curing gastric ulcer | |
| CN1814245A (en) | Chinese medicine remedy for treating cervical vertebra disease | |
| CN1698735A (en) | Medicine for treating psoriasis | |
| CN1418696A (en) | Traditional Chinese medicine prepn. for treating cervical vertebra disease | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN1134837A (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
| CN1148214C (en) | Medicine for curing bronchial asthma disease and its preparing method | |
| CN1181879C (en) | Analgestic plaster | |
| CN1074670C (en) | Medicine for the treatment of rheumatism and arthritis | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN1294984C (en) | Combination of Chinese traditional medicine for treating rheumatoid arthritis and artjritis pauperum | |
| CN1236809C (en) | Trauma treating medicament and method for making same | |
| CN1381250A (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
| CN1615929A (en) | Medicine for treating wind-dampness syndrome | |
| CN1814083A (en) | Collateral-flow-activating pain-relieving ointment of Radix Torricelliae Angucatae for treating affection by dampness | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN1911357A (en) | Medicinal composition for treating hyperosteogency | |
| CN1422639A (en) | Dral medicine for treating rheumatism and atrophic diseases | |
| CN1076201C (en) | Chinese medicine for treating rheumatoid disease | |
| CN1181864C (en) | Pain eliminating liquor No.1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |